8 February 2016 - Britain's cost watchdog has recommended that patients with high cholesterol should not get Sanofi and Regeneron's new cholesterol-lowering injection Praluent, although Amgen's similar drug Repatha will be available.

For more details, go to: http://www.reuters.com/article/us-sanofi-amgen-britain-idUSKCN0VH1F6